ModivCare Inc. (NASDAQ:MODV – Get Free Report) was the target of a significant increase in short interest in the month of December. As of December 15th, there was short interest totalling 644,300 shares, an increase of 18.3% from the November 30th total of 544,500 shares. Currently, 4.6% of the company’s shares are short sold. Based on an average daily trading volume, of 281,200 shares, the short-interest ratio is currently 2.3 days.
Analysts Set New Price Targets
A number of equities research analysts have commented on MODV shares. Barrington Research reissued an “outperform” rating and issued a $25.00 price objective on shares of ModivCare in a research report on Monday, November 18th. Jefferies Financial Group lowered their price target on ModivCare from $25.00 to $14.00 and set a “hold” rating on the stock in a report on Friday, September 13th. Finally, Lake Street Capital reduced their price objective on ModivCare from $50.00 to $30.00 and set a “buy” rating for the company in a research note on Tuesday, September 17th.
Insider Transactions at ModivCare
Hedge Funds Weigh In On ModivCare
Several hedge funds have recently bought and sold shares of the stock. Wilmington Savings Fund Society FSB acquired a new stake in shares of ModivCare during the 3rd quarter worth about $43,000. Barclays PLC boosted its position in ModivCare by 249.4% during the third quarter. Barclays PLC now owns 15,235 shares of the company’s stock worth $218,000 after acquiring an additional 10,875 shares during the last quarter. K2 Principal Fund L.P. boosted its position in ModivCare by 24.6% during the third quarter. K2 Principal Fund L.P. now owns 158,820 shares of the company’s stock worth $2,268,000 after acquiring an additional 31,334 shares during the last quarter. State Street Corp grew its stake in ModivCare by 1.5% in the 3rd quarter. State Street Corp now owns 349,750 shares of the company’s stock worth $4,994,000 after acquiring an additional 5,115 shares during the period. Finally, Repertoire Partners LP acquired a new position in ModivCare in the 3rd quarter valued at $178,000.
ModivCare Trading Up 3.2 %
Shares of ModivCare stock opened at $11.35 on Monday. The company has a quick ratio of 0.80, a current ratio of 0.80 and a debt-to-equity ratio of 103.63. The firm has a market cap of $162.12 million, a price-to-earnings ratio of -0.88, a price-to-earnings-growth ratio of 2.77 and a beta of 0.52. ModivCare has a 52-week low of $10.25 and a 52-week high of $52.33. The company’s 50-day simple moving average is $15.81 and its 200-day simple moving average is $20.18.
ModivCare (NASDAQ:MODV – Get Free Report) last issued its earnings results on Wednesday, November 6th. The company reported $0.45 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.49 by ($0.04). ModivCare had a positive return on equity of 26.14% and a negative net margin of 6.57%. The business had revenue of $702.04 million for the quarter, compared to analysts’ expectations of $711.28 million. During the same period last year, the company posted $1.35 earnings per share. The business’s quarterly revenue was up 2.2% on a year-over-year basis. As a group, equities research analysts anticipate that ModivCare will post 0.64 earnings per share for the current year.
About ModivCare
ModivCare Inc, a technology-enabled healthcare services company, provides a suite of integrated supportive care solutions for public and private payors and their members. The company operates through four segments: Non-Emergency Medical Transportation (NEMT), Personal Care, Remote Patient Monitoring (RPM), and Corporate and Other.
Featured Articles
- Five stocks we like better than ModivCare
- Russell 2000 Index, How Investors Use it For Profitable Trading
- Power Up: Gaming Industry Expansion Fuels Stock Opportunities
- What Are Earnings Reports?
- These 3 Quirky ETFs May Be Strong Plays in 2025
- Which Wall Street Analysts are the Most Accurate?
- Buffett Takes the Bait; Berkshire Buys More Oxy in December
Receive News & Ratings for ModivCare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ModivCare and related companies with MarketBeat.com's FREE daily email newsletter.